• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Transcatheter Aortic Valve Implantation Part I: A systematic review of health economic evaluations]
2017     HAYES, Inc. Coronary artery calcium scoring for risk assessment and stratification of coronary artery disease in asymptomatic adults
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Saxagliptin/metformin (type 2 diabetes) - benefit assessment according to §35a Social Code Book V]
2017     HAYES, Inc. Flow diverter devices for intracranial aneurysms: a review of reviews
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Glecaprevir/pibrentasvir (chronic hepatitis C) – benefit assessment according to § 35a Social Code Book V]
2017     HAYES, Inc. High-Intensity focused ultrasound for salvage therapy of recurrent prostate cancer
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ceritinib (non-small cell lung cancer) – benefit assessment according to §35a Social Code Book V]
2017     HAYES, Inc. Hydrogen breath tests for diagnosis of small intestinal bacterial overgrowth in functional bowel disorders
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcorneal electrical stimulation for retinitis pigmentosa (addendum to commission E14-07)]
2017     HAYES, Inc. Occupational therapy for attention-deficit/hyperactivity disorder (ADHD)
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Transcorneal electrical stimulation for retinitis pigmentosa]
2017     HAYES, Inc. Percutaneous kyphoplasty for osteoporotic vertebral compression fractures
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Inotuzumab ozogamicin (acute lymphocytic leukaemia) - assessment according to §35a (para 1, sentence 10) Social Code Book V]
2017     NIHR Health Technology Assessment programme Facet joint injections for people with persistent non-specific low back pain (Facet Injection Study): a feasibility study for a randomised controlled trial
2017     HAYES, Inc. Proton beam therapy for non-small cell lung cancer
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Alectinib (non-small-cell lung cancer) - addendum to commission A17-19]
2017     HAYES, Inc. Radiofrequency ablation for sacroiliac joint denervation for chronic low back pain
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tofacitinib (rheumatoid arthritis) - addendum to commission A17-18]
2017     HAYES, Inc. Collagen meniscus implant (CMI) (Menaflex; Ivy Sports Medicine LLC) for meniscal repair
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib (lung cancer) - addendum to commission A17-20]
2017     HAYES, Inc. Continuous subcutaneous treprostinil for treatment of pulmonary arterial hypertension
2017     Health Quality Ontario (HQO) Fibreglass total contact casting, removable cast walkers, and irremovable cast walkers to treat diabetic neuropathic foot ulcers: a health technology assessment
2017     The Swedish Council on Health Technology Assessment (SBU) [Occupational health and safety – chemical exposure]
2017     HAYES, Inc. Dexamethasone intravitreal implant (Ozurdex; Allergan Inc.) for treatment of retinal vein occlusion
2017     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment update
2017     HAYES, Inc. Percutaneous electrical nerve stimulation for treatment of low back pain
2017     Health Quality Ontario (HQO) Electrical stimulation for pressure injuries: a health technology assessment
2017     The Swedish Council on Health Technology Assessment (SBU) [Treatment options of arm fractures in the elderly]
2017     HAYES, Inc. Percutaneous endoscopic lumbar discectomy for primary lumbar disc herniation
2017     Health Quality Ontario (HQO) Psychotherapy for major depressive disorder and generalized anxiety disorder: a health technology assessment
2017     HAYES, Inc. Subcutaneous implantable cardioverter defibrillator (S-ICD) for prevention of sudden cardiac death
2017     Health Quality Ontario (HQO) Fibreglass total contact casting, removable cast walkers, and irremovable cast walkers to treat diabetic neuropathic foot ulcers: OHTAC recommendation
2017     HAYES, Inc. clonoSEQ (Adaptive Biotechnologies)
2017     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC Recommendation
2017     HAYES, Inc. GeneSight Psychotropic (Assurex Health Inc.)
2017     Health Quality Ontario (HQO) Electrical stimulation for pressure injuries: OHTAC recommendation
2017     HAYES, Inc. Prometheus IBD sgi Diagnostic (Prometheus Laboratories Inc.)
2017     Health Quality Ontario (HQO) Psychotherapy for major depressive disorder and generalized anxiety disorder: OHTAC recommendation
2017     NIHR Health Technology Assessment programme Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial (DeCoDer study)
2017     NIHR Health Services and Delivery Research programme Can Health-care Assistant Training improve the relational care of older people? (CHAT) A development and feasibility study of a complex intervention
2017     Health Quality Ontario (HQO) Home-based subcutaneous infusion of immunoglobulin for primary and secondary immunodeficiencies: OHTAC recommendation
2017     NIHR Health Services and Delivery Research programme A mixed-methods study exploring the characteristics and needs of long stay patients in high and medium secure settings in England: implications for service organisation
2017     NIHR Health Technology Assessment programme A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial
2017     NIHR Health Services and Delivery Research programme Updated meta-review of evidence on support for carers
2017     NIHR Health Technology Assessment programme Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project
2017     NIHR Health Services and Delivery Research programme REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care
2017     NIHR Health Technology Assessment programme Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
2017     NIHR Health Services and Delivery Research programme Accessibility and implementation in the UK NHS services of an effective depression relapse prevention programme: learning from mindfulness-based cognitive therapy through a mixed-methods study
2017     NIHR Health Technology Assessment programme International multicentre randomised controlled trial of improvisational music therapy for children with autism spectrum disorder: TIME-A study
2017     NIHR Health Services and Delivery Research programme Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial: a three-armed randomised controlled trial of financial incentives
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Interventions to improve foster children's mental and physical health]
2017     NIHR Public Health Research (PHR) programme Increasing boys' and girls' intention to avoid teenage pregnancy: a cluster randomised control feasibility trial of an interactive video drama based intervention in post-primary schools in Northern Ireland
2017     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) [Methods to increase chronically ill patients' participation in health care and services]
2017     NIHR Health Technology Assessment programme Cognitive behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial
2017     NIHR Health Technology Assessment programme A novel peer-support intervention using motivational interviewing for breastfeeding maintenance:a UK feasibility study
2017     NIHR Health Technology Assessment programme Prehospital randomised assessment of a mechanical compression device in out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised trial and economic evaluation
2017     NIHR Health Technology Assessment programme Pre-conception care for women with type 1 or type 2 diabetes: a mixed methods study exploring uptake of pre-conception care
2017     NIHR Health Technology Assessment programme Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES trial
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brodalumab (plaque psoriasis) – benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ledipasvir/sofosbuvir (hepatitis C) – benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Home-based health promotion for older people with mild frailty: the HomeHealth intervention development and feasibility RCT
2017     NIHR Health Technology Assessment programme Modifying Alcohol Consumption to Reduce Obesity (MACRO): development and feasibility trial of a complex community-based intervention for men
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Daratumumab (multiple myeloma) – benefit assessment according to §35a Social Code Book V]
2017     NIHR Public Health Research (PHR) programme Steps Towards Alcohol Misuse Prevention Programme (STAMPP): a school- and community-based cluster randomised controlled trial
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sarilumab (rheumatoid arthritis) – benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Carfilzomib (multiple myeloma) – benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sofosbuvir/velpatasvir/voxilaprevir (chronic hepatitis C) – benefit assessment according to §35a Social Code Book V]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Decision aid for biomarker tests in breast cancer - addendum to commission D14-01]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Etelcalcetide (secondary hyperparathyroidism)]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (squamous cell carcinoma of the head and neck). Second addendum to A-17-24]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Invitation and decision aid for cervical cancer screening]
2017     NIHR Health Technology Assessment programme The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (squamous cell carcinoma of the head and neck) - addendum to Commission A17-24 ]
2017     NIHR Health Technology Assessment programme Managing Faecal INcontinence in people with advanced dementia resident in Care Homes (FINCH) study: a realist synthesis of the evidence
2017     NIHR Health Technology Assessment programme Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017     NIHR Health Technology Assessment programme A systematic review and economic evaluation of adalimumab and dexamethasone for treating non-infectious intermediate uveitis, posterior uveitis or panuveitis in adults
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Assessing the performance of methodological search filters to improve the efficiency of evidence information retrieval: five literature reviews and a qualitative study
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial
2017     NIHR Health Technology Assessment programme Facet-joint injections for non-specific low back pain: a feasibility RCT
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of a multifaceted podiatry intervention for falls prevention in older people: a multicentre cohort randomised controlled trial (the REducing Falls with ORthoses and a Multifaceted podiatry intervention trial)
2017     NIHR Health Technology Assessment programme Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study
2017     NIHR Health Technology Assessment programme Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation
2017     NIHR Health Technology Assessment programme Surveillance versus ablation for incidentally diagnosed small renal tumours: the SURAB feasibility RCT
2017     HAYES, Inc. Acclarent eustachian tube balloon dilation for the treatment of eustachian tube dysfunction in adults
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tonsillotomy for recurrent acute tonsillitis and for hyperplasia of the tonsils]
2017     HAYES, Inc. Bielfeld eustachian tube balloon dilation for the treatment of chronic eustachian tube dysfunction in adults
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Macitentan (pulmonary arterial hypertension) - Benefit assessment according to §35a Social Code Book V]
2017     HAYES, Inc. Buprenorphine extended-release implant (Probuphine; Braeburn Pharmaceuticals Inc.) for opioid use disorder
2017     NIHR Health Technology Assessment programme Development and validation of Prediction models for Risks of complications in Early-onset Pre-eclampsia (PREP): a prospective cohort study
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trifluridine/tipiracil (colorectal cancer): Addendum to Commission A16-54]
2017     HAYES, Inc. Impella CP (Abiomed) for use in adult patients with cardiogenic shock
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cabozantinib (renal cell carcinoma) - Benefit assessment according to §35a Social Code Book V]
2017     HAYES, Inc. Noncontact low-frequency ultrasound using the MIST Therapy System (Celleration Inc.) for treatment of venous leg ulcers
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Targeted lung denervation by catheter ablation in chronic obstructive lung disease: Assessments according to §137h SGB V]
2017     HAYES, Inc. Peripheral nerve ablation for treatment of osteoarthritic knee pain
2017     NIHR Health Technology Assessment programme CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V]
2017     HAYES, Inc. Propel and propel mini bioabsorbable steroid-releasing sinus implants for treatment of chronic rhinosinusitis in adults